BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Alcohol
,
Trichostatin A
,
rs2476601
,
PBX1
,
Apoptosis
,
Allergy to pollen
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
rubella
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022.
Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019.
Rubella.
A case of congenital rubella syndrome and epidemiology of related cases in China, 2014-2023.
Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case ident…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Coadministration of Measles-rubella and Rotavirus Vaccines
Rubella Susceptibility in Multiparous Women
Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live
Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Meas…
Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rub…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ